Boston keratoprosthesis for the treatment of corneal blindness clinical effectiveness and cost-effectiveness

This Rapid Response report aims to review the clinical and cost-effectiveness of Boston Type 1 (KPro) keratoprosthesis for the treatment of corneal blindness

Bibliographic Details
Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2016, 22 April 2016
Series:Rapid response report: summary with critical appraisal
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:This Rapid Response report aims to review the clinical and cost-effectiveness of Boston Type 1 (KPro) keratoprosthesis for the treatment of corneal blindness
Item Description:"CADTH Rapid Response Service."
Physical Description:1 PDF file (16 pages) illustration